MELLODDY aims to leverage the world’s largest collection of small molecules with known biochemical or cellular activity to enable more accurate predictive models and increase efficiencies in drug discovery.

This project aims to enhance predictive Machine Learning models on decentralised data of 10 pharmaceutical companies, without exposing proprietary information.